Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69


Improving retention in the early infant diagnosis of HIV program in rural Mozambique by better service integration.

Ciampa PJ, Burlison JR, Blevins M, Sidat M, Moon TD, Rothman RL, Vermund SH.

J Acquir Immune Defic Syndr. 2011 Sep 1;58(1):115-9. doi: 10.1097/QAI.0b013e31822149bf.


Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.

PLoS Med. 2007 Aug;4(8):e257.


Outcomes and challenges of scaling up comprehensive PMTCT services in rural Swaziland, Southern Africa.

Bancheno WM, Mwanyumba F, Mareverwa J.

AIDS Care. 2010 Sep;22(9):1130-5. doi: 10.1080/09540121003615079.


A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL; South African Intrapartum Nevirapine Trial (SAINT) Investigators.

J Infect Dis. 2003 Mar 1;187(5):725-35. Epub 2003 Feb 24.


Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.

Chalermchockcharoenkit A, Culnane M, Chotpitayasunondh T, Vanprapa N, Leelawiwat W, Mock PA, Asavapiriyanont S, Teeraratkul A, McConnell MS, McNicholl JM, Tappero JW.

Clin Infect Dis. 2009 Jul 15;49(2):299-305. doi: 10.1086/599612.


Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.

Clin Infect Dis. 2008 Feb 15;46(4):611-21. doi: 10.1086/526780.


Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.

Suksomboon N, Poolsup N, Ket-Aim S.

J Clin Pharm Ther. 2007 Jun;32(3):293-311. Review.


Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial.

McIntyre JA, Hopley M, Moodley D, Eklund M, Gray GE, Hall DB, Robinson P, Mayers D, Martinson NA.

PLoS Med. 2009 Oct;6(10):e1000172. doi: 10.1371/journal.pmed.1000172. Epub 2009 Oct 27.


Antiretroviral therapy for prevention of mother-to-child HIV transmission : focus on single-dose nevirapine.

Giaquinto C, Rampon O, De Rossi A.

Clin Drug Investig. 2006;26(11):611-27. Review.


HIV infection and zidovudine use in childbearing women.

Sia J, Paul S, Martin RM, Cross H.

Pediatrics. 2004 Dec;114(6):e707-12. Epub 2004 Nov 15.


Effectiveness of a PMTCT programme in rural Western Kenya.

Azcoaga-Lorenzo A, Ferreyra C, Alvarez A, Palma PP, Velilla E, del Amo J.

AIDS Care. 2011 Mar;23(3):274-80. doi: 10.1080/09540121.2010.507750.


Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.

Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.

AIDS. 2008 Sep 12;22(14):1815-20. doi: 10.1097/QAD.0b013e32830b8ab9.


Addressing poor retention of infants exposed to HIV: a quality improvement study in rural Mozambique.

Ciampa PJ, Tique JA, Jumá N, Sidat M, Moon TD, Rothman RL, Vermund SH.

J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):e46-52. doi: 10.1097/QAI.0b013e31824c0267. Erratum in: J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):e106.


From research to practice: use of short course zidovudine to prevent mother-to-child HIV transmission in the context of routine health care in Northern Thailand.

Thaineua V, Sirinirund P, Tanbanjong A, Lallemant M, Soucat A, Lamboray JL.

Southeast Asian J Trop Med Public Health. 1998 Sep;29(3):429-42.


A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.

Thistle P, Spitzer RF, Glazier RH, Pilon R, Arbess G, Simor A, Boyle E, Chitsike I, Chipato T, Gottesman M, Silverman M.

Clin Infect Dis. 2007 Jan 1;44(1):111-9. Epub 2006 Nov 22.


Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana.

Shapiro RL, Thior I, Gilbert PB, Lockman S, Wester C, Smeaton LM, Stevens L, Heymann SJ, Ndung'u T, Gaseitsiwe S, Novitsky V, Makhema J, Lagakos S, Essex M.

AIDS. 2006 Jun 12;20(9):1281-8.


Towards the complete eradication of mother-to-child HIV/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa.

Ilboudo D, Simpore J, Ouermi D, Bisseye C, Sagna T, Odolini S, Buelli F, Pietra V, Pignatelli S, Gnoula C, Nikiema JB, Musumeci S.

Braz J Infect Dis. 2010 May-Jun;14(3):219-24.


Operational effectiveness of single-dose nevirapine in preventing mother-to-child transmission of HIV.

Colvin M, Chopra M, Doherty T, Jackson D, Levin J, Willumsen J, Goga A, Moodley P; Good Start Study Group.

Bull World Health Organ. 2007 Jun;85(6):466-73.

Items per page

Supplemental Content

Write to the Help Desk